Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides

被引:11
作者
Babkov, Denis A. [1 ]
Khandazhinskaya, Anastasia L. [2 ]
Chizhov, Alexander O. [3 ]
Andrei, Graciela [4 ]
Snoeck, Robert [4 ]
Seley-Radtke, Katherine L. [5 ]
Novikov, Mikhail S. [1 ]
机构
[1] Volgograd State Med Univ, Dept Pharmaceut & Toxicol Chem, Volgograd 400131, Russia
[2] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia
[3] Russian Acad Sci, Zelinsky Inst Organ Chem, Moscow 119991, Russia
[4] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[5] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA
基金
俄罗斯基础研究基金会;
关键词
Human cytomegalovirus; Varicella zoster virus; Antiviral; Non-nucleoside inhibitor; Uracil; HUMAN CYTOMEGALOVIRUS; NUCLEOSIDE ANALOGS; DERIVATIVES; POLYMERASE; AGENTS; PREVENTION; MANAGEMENT; DESIGN; ACID; CMV;
D O I
10.1016/j.bmc.2015.09.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The need for novel therapeutic options to fight herpesvirus infections still persists. Herein we report the design, synthesis and antiviral evaluation of a new family of non-nucleoside antivirals, derived from 1-[omega-(4-bromophenoxy)alkyl]uracil derivatives - previously reported inhibitors of human cytomegalovirus (HCMV). Introduction of the N-(4-phenoxyphenyl)acetamide side chain at N-3 increased their potency and widened activity spectrum. The most active compounds in the series exhibit submicromolar activity against different viral strains of HCMV and varicella zoster virus (VZV) replication in HEL cell cultures. Inactivity against other DNA and RNA viruses, including herpes simplex virus 1/2, points to a novel mechanism of antiviral action. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7035 / 7044
页数:10
相关论文
共 29 条
  • [1] Scaffold hopping: Exploration of acetanilide-containing uracil analogues as potential NNRTIs
    Babkov, Denis A.
    Valuev-Elliston, Vladimir T.
    Paramonova, Maria P.
    Ozerov, Alexander A.
    Ivanov, Alexander V.
    Chizhov, Alexander O.
    Khandazhinskaya, Anastasia L.
    Kochetkov, Sergey N.
    Balzarini, Jan
    Daelemans, Dirk
    Pannecouque, Christophe
    Seley-Radtke, Katherine L.
    Novikov, Mikhail S.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) : 1069 - 1081
  • [2] The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
    Boeckh, M
    Nichols, WG
    [J]. BLOOD, 2004, 103 (06) : 2003 - 2008
  • [3] Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies (Reprinted from Biol Blood Marrow Transplant, vol 21, pg 24-29, 2015)
    Boeckh, Michael
    Murphy, William J.
    Peggs, Karl S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S19 - S24
  • [4] Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future
    Boeckh, Michael
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 305 - 309
  • [5] Cu-catalyzed alkylation of Grignard reagents:: A new efficient procedure
    Cahiez, G
    Chaboche, C
    Jézéquel, M
    [J]. TETRAHEDRON, 2000, 56 (18) : 2733 - 2737
  • [6] COLLA L, 1982, EUR J MED CHEM, V17, P569
  • [7] Recommendations for the management of herpes zoster
    Dworkin, Robert H.
    Johnson, Robert W.
    Breuer, Judith
    Gnann, John W.
    Levin, Myron J.
    Backonja, Miroslav
    Betts, Robert F.
    Gershon, Anne A.
    Haanpaa, Maija L.
    McKendrick, Michael W.
    Nurmikko, Turo J.
    Oaklander, Anne Louise
    Oxman, Michael N.
    Pavan-Langston, Deborah
    Petersen, Karin L.
    Rowbotham, Michael C.
    Schmader, Kenneth E.
    Stacey, Brett R.
    Tyring, Stephen K.
    van Wijck, Albert J. M.
    Wallace, Mark S.
    Wassilew, Sawko W.
    Whitley, Richard J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 : S1 - S26
  • [8] Design and synthesis of a potent macrocyclic 1,6-napthyridine anti-human cytomegalovirus (HCMV) inhibitors
    Falardeau, G
    Lachance, H
    St-Pierre, A
    Yannopoulos, CG
    Drouin, M
    Bédard, J
    Chan, L
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) : 1693 - 1695
  • [9] SYNTHESIS OF ACYCLONUCLEOSIDE HYDROXAMIC ACIDS AS INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
    FARR, RA
    BEY, P
    SUNKARA, PS
    LIPPERT, BJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) : 1879 - 1885
  • [10] High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria
    Fowotade, Adeola
    Okonko, Iheanyi Omezuruike
    Agbede, Olajide Olubunmi
    Suleiman, S. T.
    [J]. AFRICAN HEALTH SCIENCES, 2015, 15 (01) : 1 - 8